A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells. - Wikidata - awgldk - TriplyDB

A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells.

A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells.

http://www.wikidata.org/entity/Q42837168

about

A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies Autoantibodies induced by chimeric cytokine-HIV envelope glycoprotein immunogens.Elicitation of HIV-1-neutralizing antibodies against the CD4-binding site.Enhanced immunogenicity of HIV-1 envelope gp140 proteins fused to APRIL.Designing a soluble near full-length HIV-1 gp41 trimer.Chimeric HIV-1 envelope glycoproteins with potent intrinsic granulocyte-macrophage colony-stimulating factor (GM-CSF) activity.An HIV-1 envelope glycoprotein trimer with an embedded IL-21 domain activates human B cells Comparative Immunogenicity of Evolved V1V2-Deleted HIV-1 Envelope Glycoprotein Trimers HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity Targeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responses.Optimization of HIV-1 Envelope DNA Vaccine Candidates within Three Different Animal Models, Guinea Pigs, Rabbits and Cynomolgus Macaques Engineering and Characterization of a Fluorescent Native-Like HIV-1 Envelope Glycoprotein Trimer.T cell responses to viral infections - opportunities for Peptide vaccination.Improved outlook on HIV-1 prevention and vaccine development.Immunosilencing a highly immunogenic protein trimerization domain.

P2860

Q28299280-0C9C3FCA-804B-47A5-A410-8CE6435AE5E8 Q33601372-2F062F38-BD27-48A0-B26B-66ADBEC38D34 Q34133551-64297BE3-202F-486C-A6F6-0B905D9D9C97 Q34232224-489EB4A5-8A2A-4AA3-B9EC-30E2EBD22EFE Q34489464-7666778E-41FD-44B9-8399-26FEB32C668A Q34658136-5826941A-E39C-430A-B33A-5E93F3E6E177 Q34796885-295C1E99-19C5-44E6-8D53-3A18C595865C Q34807480-C0E662B3-0E27-462E-A1C1-1DCFC36769DC Q35108680-A250BF96-F9F3-42C2-80AC-4CAD30579C56 Q35826171-13C7FE8E-3448-4854-B253-F2FE0D8A9411 Q35826692-F08EEA0A-88A3-49CA-9326-CAC8D0349F71 Q36409575-F12ED7BF-3F1C-4457-9F4E-85F600AB5D83 Q37718978-4A7FAE39-0EEA-48AD-873B-F0BD3F3C4B80 Q38009870-48BA9609-BB49-4BF3-A716-B9FB52480FC9 Q41506957-CABF9F9D-0D38-4245-A32A-580BC36C7EA8

P2860

A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells.

http://www.wikidata.org/entity/Q42837168

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

A stabilized HIV-1 envelope gl ...... and activates dendritic cells.

@en

A stabilized HIV-1 envelope gl ...... and activates dendritic cells.

@nl

type

label

A stabilized HIV-1 envelope gl ...... and activates dendritic cells.

@en

A stabilized HIV-1 envelope gl ...... and activates dendritic cells.

@nl

prefLabel

A stabilized HIV-1 envelope gl ...... and activates dendritic cells.

@en

A stabilized HIV-1 envelope gl ...... and activates dendritic cells.

@nl

P1433

Q42837168-ED146D9C-3948-4725-A122-FED3779C5284

P1476

Q42837168-C4C54B81-F33D-466F-A357-CB9C00E1AC33

P2093

Q42837168-00AA167E-3A4B-42A2-B17C-9DC00E96A593

Q42837168-247CBEBE-C194-4747-92B2-C839F3E005F5

Q42837168-3533EB63-D86E-4A0C-9DB8-2D0CDFEFAE57

Q42837168-6891BB56-4BCC-41C2-93B9-C5D79F4F3459

Q42837168-6D9215C0-C50E-4BFE-B727-C00CB6EA9032

Q42837168-7EDCEAD6-FC69-4233-A91D-0E8BE23F8414

Q42837168-8DED4312-9C82-4B1D-BB7C-7DEF2323F1E6

Q42837168-993BC421-C065-470A-B2F6-580821C0B999

Q42837168-C0AD0B63-AD44-4A22-BA8B-A3567BAC9698

Q42837168-D36337FE-36E3-4C95-AC51-072C5907AED1

P2860

Q42837168-01F78ED4-39D5-4FFC-BEA2-09109C31579A

Q42837168-020AAA9D-BAA8-4F8D-8BBA-74D135F816A8

Q42837168-05AE4E2A-B840-4255-BE33-6D562B8ECD40

Q42837168-0B346A7F-E456-4314-8B4C-C9578FE85F4B

Q42837168-19AA96A8-D78A-4A0A-9890-412D39F38CF7

Q42837168-262959E1-A0D4-4469-AB9A-C17F4EB2F077

Q42837168-272E8420-4231-4F59-BAA1-07D939D2A3FE

Q42837168-2912DE0F-1DC1-446D-91FC-B986012E6C45

Q42837168-2D4632EC-1DF3-4986-A6B8-1D98452D7F14

Q42837168-2E08B673-B440-47A5-A364-4FCEA0DFB8B0

P2888

Q42837168-C98425BE-A63F-4C10-98DA-16C042797977

P304

Q42837168-98A52383-1E12-4495-81B6-F743BBB78CE3

P31

Q42837168-DD58407A-33CA-44DC-B896-DBD362C8F46B

P356

Q42837168-528E695B-C6CC-4D67-BCF0-53E1A9AB351F

P478

Q42837168-2E7E1587-8DF0-4B8F-A5C2-1A068171668D

P577

Q42837168-EABE4318-5BB9-4723-A9C5-96287B556CB0

P5875

Q42837168-6A4696B5-A2C7-4C25-BA42-D0A698833569

P6179

Q42837168-5338453E-4359-4F88-88F3-508812841D90

P698

Q42837168-C8155B8B-9731-4854-9720-48E26C10BA2A

P932

Q42837168-8E5F5371-866C-4AFD-BBEC-55076C45043F

P356

P1433

P1476

A stabilized HIV-1 envelope gl ...... and activates dendritic cells.

@en

P2093

Ben Berkhout

http://www.w3.org/2001/XMLSchema#string

Carolien van de Sandt

http://www.w3.org/2001/XMLSchema#string

Dirk Eggink

http://www.w3.org/2001/XMLSchema#string

Ilja Bontjer

http://www.w3.org/2001/XMLSchema#string

John P Moore

http://www.w3.org/2001/XMLSchema#string

Kathryn David

http://www.w3.org/2001/XMLSchema#string

Katie Matthews

http://www.w3.org/2001/XMLSchema#string

Mark Melchers

http://www.w3.org/2001/XMLSchema#string

Robert P de Vries

http://www.w3.org/2001/XMLSchema#string

Rogier W Sanders

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of an isoleucine-zipper trimer

CD40-CD40 ligand

Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial

Differential antigen processing by dendritic cell subsets in vivo

Analysis of molecular masses and oligomeric states of protein complexes by blue native electrophoresis and isolation of membrane protein complexes by two-dimensional native electrophoresis

Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form

Improving defences at the portal of HIV entry: mucosal and innate immunity.

HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.

HIV-1 and influenza antibodies: seeing antigens in new ways

Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution.

P2888

P304

48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-4690-8-48

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51234760

http://www.w3.org/2001/XMLSchema#string

P6179

1009814695

http://www.w3.org/2001/XMLSchema#string

P698

21689404

http://www.w3.org/2001/XMLSchema#string

P932

3141652

http://www.w3.org/2001/XMLSchema#string